Low-Grade Albuminuria Is Associated with Metabolic Syndrome and Its Components in Middle-Aged and Elderly Chinese Population

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Zhang, Jie ^a   Chen, Yuhong ^a,b   Xu, Yu ^a,b   Li, Mian ^a   Wang, Tiange ^a   Xu, Baihui ^a   Sun, Jichao ^a,c   Xu, Min ^a,b   Lu, Jieli ^a,b   Bi, Yufang ^a,b  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ALBUMINURIA; ARTICLE; BODY MASS; CHINESE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENDER; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; URINARY ALBUMIN TO CREATININE RATIO; URINE LEVEL; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COMPLICATION; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; URINE;

ADULT; AGE FACTORS; AGED; ALBUMINURIA; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; SEX FACTORS;

EID: 84879271436     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065597     Document Type: Article

References (47)

1. Gerstein HC, Mann JF, Pogue J, Dinneen SF, Hallé JP, et al. (2000) Prevalence and determinants of micro-albuminuria in high-risk diabetic and non-diabetic patients in the Heart Outcomes Prevention Evaluation Study. Diabetes Care 23: B35-39.
2. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, et al. (2001) Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and non-diabetic individuals. JAMA 286: 421-426.
3. De Leeuw PW, Thijs L, Birkenhäger WH, Voyaki SM, Efstratopoulos AD,et al. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators (2002) Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur trial. J Am SocNephrol 13: 2213-2222.
4. Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, et al. (2002) Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 51: 1157-1165.
5. Valmadrid CT, Klein R, Moss SE, Klein BE, (2000) The risk of cardiovascular disease mortality associated with micro-albuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 160: 1093-1100.
6. Wang TJ, Evans JC, Meigs JB, Rifai N, Fox CS, et al. (2005) Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation 111: 1370-1376.
7. Arnlöv J, Evans JC, Meigs JB, Wang TJ, Fox CS, et al. (2005) Low-grade albuminuria and incidence of cardiovascular disease events in non-hypertensive and non-diabetic individuals: the Framingham Heart Study. Circulation 112: 969-975.
8. Gu D, Reynolds K, Wu X, Chen J, Duan X, et al. (2005) Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365: 1398-1405.
9. Palaniappan L, Carnethon M, Fortmann SP, (2003) Association between micro-albuminuria and the metabolic syndrome: NHANES III. Am J Hypertens 16: 952-958.
10. Lee JE, Huh W, Son HJ, Kim YG, Kim DJ, et al. (2007) Association of metabolic syndrome with micro-albuminuria in non-hypertensive type 2 diabetic patients. Nephron Clin Pract 106: C98-103.
11. Esteghamati A, Rashidi A, Khalilzadeh O, Ashraf H, Abbasi M, (2010) Metabolic syndrome is independently associated with micro-albuminuria in type 2 diabetes. Acta Diabetol 47: 125-130.
12. Hao Z, Konta T, Takasaki S, Abiko H, Ishikawa M, et al. (2007) The association between microalbuminuria and metabolic syndrome in the general population in Japan: the Takahata study. Intern Med 46: 341-346.
13. Vyssoulis G, Karpanou E, Spanos P, Kyvelou SM, Adamopoulos D, et al. (2010) Urine albumin excretion, within normal range, reflects increasing prevalence of metabolic syndrome in patients with essential hypertension. J Clin Hypertens (Greenwich) 12: 597-602.
14. Ritz E, Viberti GC, Ruilope LM, Rabelink AJ, Izzo JL Jr, et al. (2010) Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study. Diabetologia 53: 49-57.
15. Patel AA, Bloomgarden ZT, Futterweit W, (2008) Premicroalbuminuria in women with polycystic ovary syndrome: a metabolic risk marker. Endocr Pract 14: 193-200.
16. Huang Y, Bi Y, Xu M, Ma Z, Xu Y, et al. (2012) Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly Chinese. Arterioscler Thromb Vasc Biol 32: 2321-2326.
17. Sun K, Liu Y, Dai M, Li M, Yang Z, et al. (2012) Accessing Autonomic Function Can Early Screen Metabolic Syndrome. PLoS ONE 7: e43449.
18. Li M, Xu Y, Xu M, Ma L, Wang T, et al. (2012) Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese. J Clin Endocrinol Metab 97: 2033-2038.
19. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ) (2005) http://www.ipaq.ki.se/scoring.pdf.
20. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, et al. (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am SocNephrol 17: 2937-2944.
21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
22. Alberti KG, Zimmet P, (2005) Shaw J. IDF Epidemiology Task Force Consensus Group (2005) The metabolic syndrome-a new worldwide definition. Lancet 366: 1059-1062.
23. Zhou BF. Cooperative Meta-Analysis Group of the Working Group on Obesity in China (2002) Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults-study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 15: 83-96.
24. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE, (1990) Micro-albuminuria as predictor of increased mortality in elderly people. BMJ 300: 297-300.
25. Hillege HL, Fidler V, Diercks GF van Gilst WH, de Zeeuw D,et al. Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group (2002) Urinary albumin excretion predicts cardiovascular and non-cardiovascular mortality in general population. Circulation 106: 1777-1782.
26. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K, (2000) Arterial hypertension, micro-albuminuria, and risk of ischemic heart disease. Hypertension 35: 898-903.
27. Yudkin JS, Forrest RD, Jackson CA, (1988) Micro-albuminuria as predictor of vascular disease in non-diabetic subjects: Islington Diabetes Survey. Lancet 2: 530-533.
28. Romundstad S, Holmen J, Hallan H, Kvenild K, Ellekjaer H, (2003) Micro-albuminuria and all-cause mortality in treated hypertensive individuals: does sex matter? The Nord-Trøndelag Health Study (HUNT), Norway. Circulation 108: 2783-2789.
29. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, et al. (2004) Very low levels of micro-albuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110: 32-35.
30. Ingelsson E, Sundstrom J, Lind L, Risérus U, Larsson A, et al. (2007) Low-grade albuminuria and the incidence of heart failure in a community-based cohort of elderly men. Eur Heart J 28: 1739-1745.
31. Lieb W, Mayer B, Stritzke J, Doering A, Hense HW, et al. (2006) Association of low-grade urinary albumin excretion with left ventricular hypertrophy in the general population: the MONICA/KORA Augsburg Echocardiographic Substudy. Nephrol Dial Transplant 21: 2780-2787.
32. Schmieder RE, Schrader J, Zidek W, Tebbe U, Paar WD, et al. (2007) Low-grade albuminuria and cardiovascular risk: what is the evidence. Clin Res Cardio 96: 247-257.
33. Sung KC, Kim BJ, Ryu S, (2008) An association of a variety of cardiovascular risk factors with low-grade albuminuria in Korean men. Atherosclerosis 196: 320-326.
34. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A, (1989) Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia 32: 219-226.
35. Ruggenenti P, Remuzzi G, (2006) Time to abandon micro-albuminuria? Kidney Int 70: 1214-1222.
36. Pedrinelli R, Dell'Omo G, Di Bello V, Pontremoli R, Mariani M, (2002) Micro-albuminuria: an integrated marker of cardiovascular risk in essential hypertension. J Hum Hypertens 16: 79-89.
37. Pontremoli R, Cheli V, Sofia A, Tirotta A, Ravera M, et al. (1995) Prevalence of micro- and macro-albuminuria and their relationship with other cardiovascular risk factors in essential hypertension. Nephrol Dial Transplant 10: 6-9.
38. Winocour PH, Harland JO, Millar JP, Laker MF, Alberti KG, (1992) Micro-albuminuria and associated cardiovascular risk factors in the community. Atherosclerosis 93: 71-81.
39. Campese VM, Bianchi S, Bigazzi R, (1999) Association between hyperlipidemia and micro-albuminuria in essential hypertension. Kidney IntSuppl 71: S10-13.
40. Orchard TJ, Chang YF, Ferrell RE, Petro N, Ellis DE, (2002) Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int 62: 963-970.
41. Mykkänen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, et al. (1998) Micro-albuminuria is associated with insulin resistance in non-diabetic subjects: the Insulin Resistance Atherosclerosis Study. Diabetes 47: 793-800.
42. Pedrinelli R, Dell'Omo G, Di Bello V, Pellegrini G, Pucci L, et al. (2004) Low-grade inflammation and microalbuminuria in hypertension. Arterioscler Thromb Vasc Biol 24: 2414-2419.
43. Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, et al. (2005) Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care 28: 2525-2530.
44. Halimi JM, Bonnet F, Lange C, Balkau B, Tichet J, et al. (2008) Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study. J Hypertens 26: 2198-2206.
45. Bonnet F, Marre M, Halimi JM, Stengel B, Lange C, et al. (2006) Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study. J Hypertens 24: 1157-1163.
46. Bakker AJ, (1999) Detection of microalbuminuria: receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration. Diabetes Care 22: 307-313.
47. Eknoyan G, Hostetter T, Bakris GL, Hebert L, Levey AS, et al. (2003) Proteinuria and other markers of chronic kidney disease: a position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Am J Kidney Dis 42: 617-622.